Introduction 7.622384
: 2.5079741
Ċ 1.0427654
Amid 16.885386
st 1.2975272
Ġthe 0.70171845
Ġongoing 3.3627827
Ġchallenges 6.6983356
Ġposed 4.291905
Ġby 0.08258615
Ġthe 1.1540265
Ġglobal 3.2351892
Ġpand 6.693528
emic 0.21860173
, 1.1493529
ĠEli 12.376821
ĠLilly 1.0663495
Ġ& 3.6053746
ĠCo 0.8573508
, 3.7828395
Ġa 2.3997936
Ġrenowned 6.062202
Ġpharmaceutical 1.2519082
Ġcompany 0.25620252
Ġbased 3.007837
Ġin 0.030887937
ĠIndianapolis 1.3347399
, 0.09047713
Ġis 1.959863
Ġanticipated 9.926078
Ġto 0.057405055
Ġreport 5.4071107
Ġa 1.406821
Ġrobust 5.951787
Ġrise 6.0380926
Ġin 0.04688873
Ġthird 5.6990128
- 0.70271295
quarter 0.36854047
Ġprofits 3.1388006
. 1.2511812
ĠAnaly 4.0132527
sts 0.038828894
Ġremain 7.839831
Ġoptimistic 2.340731
Ġabout 1.4920632
Ġthe 0.37756738
Ġcompany 0.45236033
's 1.246582
Ġfuture 2.5783372
Ġfinancial 5.524824
Ġperformance 0.91546035
Ġdue 3.5787263
Ġto 0.034697566
Ġthe 1.1307869
Ġstrong 2.8625896
Ġdemand 1.6148088
Ġfor 0.3747348
Ġits 0.79389113
Ġinnovative 5.0106716
Ġdrugs 2.507209
, 1.8401117
Ġcoupled 4.3042684
Ġwith 0.009738403
Ġvarious 8.592462
Ġsuccessful 6.607511
Ġproduct 3.1340723
Ġlaunches 0.20788328
. 1.0186281
ĠNevertheless 6.0286894
, 0.011466271
Ġconcerns 4.96964
Ġlo 7.943605
om 0.014985614
Ġover 0.92245376
Ġthe 0.44651577
Ġcompany 0.6259306
's 0.03516018
Ġprofit 7.579966
Ġmargins 1.6881956
Ġand 1.4421394
Ġits 2.6926708
Ġability 1.3324314
Ġto 0.0077344277
Ġsustain 3.150493
Ġthe 2.2348185
Ġcurrent 3.6280174
Ġgrowth 1.9886905
Ġtrajectory 1.4354162
. 0.4489442
ĠAs 3.9550042
ĠEli 4.833403
ĠLilly 0.012856792
Ġ& 1.3063606
ĠCo 0.013614558
Ġprepares 5.106427
Ġto 0.35090908
Ġrelease 3.0237818
Ġits 0.385851
Ġearnings 3.3986642
Ġreport 1.0489974
, 1.8822311
Ġshareholders 7.004882
Ġand 2.5721412
Ġinvestors 1.744006
Ġclosely 8.698233
Ġmonitor 1.4510455
Ġthe 0.42207918
Ġcompany 0.30734727
's 0.06340376
Ġefforts 5.390147
Ġin 2.897493
Ġdriving 6.204145
Ġlong 3.8297417
- 0.08908192
term 0.03561665
Ġsustainable 4.3726087
Ġgrowth 1.0936512
Ġwhile 5.3468857
Ġaddressing 3.8769526
Ġmargin 9.830068
Ġpressures 1.8937197
. 0.38459158
Ċ 0.6786788
Strong 10.511484
ĠSales 6.474992
ĠPerformance 3.977839
ĠAmid 6.8086653
st 0.37428713
ĠPand 9.465445
emic 0.0016512919
: 3.3298645
Ċ 3.0326173
E 2.0999024
li 0.013517647
ĠLilly 0.0026325828
Ġ& 0.40691075
ĠCo 0.011159129
's 2.8062947
Ġoptimistic 8.475456
Ġfinancial 5.095097
Ġoutlook 1.0089213
Ġis 1.6936845
Ġprimarily 5.8657994
Ġattributed 2.808875
Ġto 0.017813295
Ġits 1.5084292
Ġsolid 4.5321403
Ġsales 1.1865034
Ġperformance 0.06517758
Ġin 1.2890116
Ġrecent 4.817215
Ġmonths 2.6410396
. 0.61838526
ĠThe 1.318655
Ġcompany 0.1620954
's 1.43567
Ġportfolio 6.8976135
Ġincludes 3.5833452
Ġcritical 7.6983347
Ġmedications 4.4923005
Ġto 3.118673
Ġtreat 0.64404213
Ġa 1.8604178
Ġrange 1.6361115
Ġof 0.0014377565
Ġconditions 2.7616
, 1.0858282
Ġincluding 0.41542798
Ġdiabetes 2.083744
, 0.26046535
Ġcancer 1.759736
, 0.32370985
Ġand 1.205008
ĠAlzheimer 3.4661357
's 0.014435117
Ġdisease 0.37340334
, 1.9098319
Ġamong 2.074312
Ġothers 0.21394873
. 0.06008925
ĠDuring 4.6598516
Ġthe 0.2418834
Ġthird 2.089884
Ġquarter 0.026431065
, 0.41290227
Ġhealthcare 8.761852
Ġproviders 2.4430969
Ġcontinued 5.5122004
Ġto 0.05849122
Ġprescribe 4.028721
Ġthese 5.3922954
Ġvital 5.814791
Ġdrugs 1.6577897
, 1.2066156
Ġresulting 3.3591044
Ġin 0.002741118
Ġsubstantial 5.2154236
Ġrevenue 1.9704907
Ġgrowth 0.5551219
Ġfor 2.1750567
Ġthe 0.44924757
Ġcompany 0.13205215
. 0.38095534
Ċ 1.8665887
The 2.4174445
Ġintroduction 8.991668
Ġof 0.032859534
Ġgroundbreaking 9.304262
Ġtherapies 4.0424275
Ġfurther 7.086257
Ġreinforced 5.732523
ĠEli 1.8333935
ĠLilly 0.0014151341
Ġ& 0.2988882
ĠCo 0.0045560277
's 0.06854987
Ġmarket 4.704375
Ġposition 1.8561462
. 1.4594387
ĠEarlier 5.1242437
Ġthis 0.1254163
Ġyear 0.39899936
, 0.03233728
Ġthe 0.7260855
Ġcompany 0.07194448
Ġlaunched 2.5408266
Ġits 1.5261127
ĠCO 9.337829
VID 7.8558397
- 3.7152092
19 6.162831
Ġantibody 6.3863444
Ġtreatment 4.190612
, 1.3632898
Ġb 10.913892
am 8.179665
lan 13.261389
iv 6.2496405
im 10.892557
ab 0.49616933
, 0.35611638
Ġproviding 6.61676
Ġa 1.5520029
Ġpotential 4.9364552
Ġsolution 2.33837
Ġto 0.5713638
Ġcombat 5.633425
Ġthe 1.1520292
Ġvirus 6.430935
. 3.7226636
ĠThe 1.6427369
Ġdrug 2.705007
Ġhas 2.1997986
Ġwitnessed 7.5828013
Ġsignificant 2.6730251
Ġuptake 3.035373
, 2.4082575
Ġwith 1.2623872
Ġdemand 5.30169
Ġlikely 5.92431
Ġto 0.324349
Ġremain 3.646508
Ġhigh 1.4497204
Ġin 2.10261
Ġthe 0.19640769
Ġcoming 1.3454688
Ġquarters 3.1846945
. 0.3191842
ĠThis 3.8528383
, 3.4851546
Ġcoupled 0.8205027
Ġwith 0.0019004669
Ġstrong 3.3726878
Ġearnings 5.5995994
Ġfrom 2.8536873
Ġother 4.456213
Ġkey 3.5645666
Ġproducts 2.048216
, 0.37153873
Ġhas 2.1213307
Ġdriven 4.1829705
Ġoverall 4.645215
Ġsales 2.2192006
Ġgrowth 0.67296094
Ġfor 2.2723577
Ġthe 0.17718947
Ġcompany 0.22212109
, 2.4241376
Ġinst 11.3432255
illing 0.3481909
Ġconfidence 0.6818325
Ġin 0.37868857
Ġinvestors 4.6286554
Ġand 2.3620672
Ġanalysts 3.3302853
Ġalike 0.68534255
. 0.078915335
Ċ 0.39419425
Pro 6.397725
fit 0.43139178
ĠMarg 1.7385321
ins 0.5448917
ĠUnder 4.5428762
ĠSc 5.950742
r 1.5088091
ut 0.0073587787
iny 0.18011813
: 0.14216024
Ċ 0.009487632
While 3.0784907
ĠEli 1.8058974
ĠLilly 0.0004321181
Ġ& 0.08881227
ĠCo 0.004822757
's 1.1541297
Ġprojected 6.060297
Ġrise 8.687518
Ġin 0.02879357
Ġprofits 1.8634243
Ġis 1.1331538
Ġencouraging 1.7194035
, 0.24743655
Ġconcerns 3.911921
Ġregarding 3.2538035
Ġits 1.3503661
Ġprofit 2.9229612
Ġmargins 0.11677002
Ġpersist 4.2326283
. 0.16422366
ĠThe 1.4911013
Ġpharmaceutical 5.413333
Ġindustry 1.7616102
Ġis 0.9165192
Ġknown 5.3796487
Ġfor 0.4599832
Ġits 0.9525636
Ġhighly 4.7459397
Ġcompetitive 0.75766915
Ġlandscape 4.399706
Ġand 1.945808
Ġincreasing 6.7836704
Ġpricing 4.187914
Ġpressures 1.0682111
. 0.6729924
ĠEli 3.3392808
ĠLilly 0.00041232194
Ġ& 0.06841953
ĠCo 0.0042104158
, 2.6443193
Ġlike 3.7856703
Ġmany 1.1933743
Ġof 2.7898078
Ġits 0.22980508
Ġpeers 0.3616149
, 0.11786004
Ġfaces 3.5880542
Ġchallenges 3.3922954
Ġassociated 5.3263903
Ġwith 0.017353663
Ġgeneric 7.776745
Ġcompetitors 4.066611
Ġentering 3.2590225
Ġthe 0.12592366
Ġmarket 0.31791413
Ġwith 3.4893448
Ġlower 1.2100223
- 2.2626688
priced 1.3830615
Ġalternatives 3.9265783
. 0.52575475
Ċ 3.7471762
The 2.1304717
Ġpressure 8.086934
Ġon 1.2074466
Ġprofit 2.5932891
Ġmargins 0.006898642
Ġis 1.1532577
Ġfurther 3.3385973
Ġexacerbated 1.1066816
Ġby 0.13921958
Ġrising 4.827056
Ġresearch 5.2129025
Ġand 0.31870973
Ġdevelopment 0.024414703
Ġ( 3.9373975
R 0.0022890107
& 0.010264406
D 0.0060678087
) 0.015403423
Ġexpenses 2.2549326
. 0.7798376
ĠDevelop 8.231128
ing 0.7748686
Ġand 3.168971
Ġbringing 7.043754
Ġnew 0.84648275
Ġdrugs 1.3958493
Ġto 0.4094736
Ġmarket 0.04742539
Ġrequires 1.8744606
Ġsignificant 1.2752992
Ġinvestment 2.9287345
, 1.2729807
Ġresulting 3.8519945
Ġin 0.002180407
Ġhigher 2.0520759
ĠR 0.94146633
& 0.0014902842
D 0.00025181074
Ġcosts 0.531881
. 0.5896875
ĠM 8.363116
aint 0.10714736
aining 0.0009814043
Ġa 1.6844571
Ġhealthy 1.9787744
Ġbalance 1.8089119
Ġbetween 0.14977264
Ġinvestment 4.069209
Ġin 3.431064
Ġinnovative 6.895331
Ġtherapies 3.9053838
Ġand 0.12357507
Ġgenerating 7.037701
Ġan 5.7973123
Ġacceptable 4.360497
Ġrate 4.4140196
Ġof 0.0039223647
Ġreturn 1.0684026
Ġhas 4.13643
Ġbecome 1.689853
Ġan 2.0603967
Ġindustry 4.8034663
- 1.0748464
wide 0.24731976
Ġchallenge 0.5623845
. 0.3482581
ĠEli 2.8554351
ĠLilly 0.00022927843
Ġ& 0.04550121
ĠCo 0.0034382641
's 1.3675277
Ġability 4.2890797
Ġto 0.00621792
Ġnavigate 4.8862624
Ġthis 0.9171217
Ġdelicate 4.8298936
Ġbalance 1.139766
Ġwill 2.1388042
Ġbe 0.73619395
Ġcrucial 2.1344166
Ġin 1.56952
Ġsustaining 3.5186589
Ġprofitability 3.1465726
Ġin 2.0677578
Ġthe 0.15431362
Ġlong 2.6139917
Ġrun 1.9864053
. 0.08887864
Ċ 0.28375068
Str 5.377561
ateg 1.4497242
ies 0.33688417
Ġand 3.356885
ĠOutlook 4.86089
: 0.3340279
Ċ 0.010967537
To 4.3943954
Ġaddress 2.5669506
Ġconcerns 4.086498
Ġover 2.350858
Ġprofit 2.5598927
Ġmargins 0.029021125
, 0.24665135
ĠEli 0.6400479
ĠLilly 0.00015481713
Ġ& 0.04459562
ĠCo 0.004064255
Ġhas 1.2672395
Ġtaken 3.2546651
Ġproactive 4.465531
Ġmeasures 1.425606
. 1.4742197
ĠThe 0.98074496
Ġcompany 0.08886034
Ġhas 0.7850013
Ġpriorit 5.6929092
ized 0.10395178
Ġcost 3.9584587
- 1.8129382
management 8.816487
Ġinitiatives 1.371627
, 1.019598
Ġseeking 6.0811486
Ġoperational 9.598044
Ġeffic 0.34032482
iencies 3.5240468e-05
Ġwhile 3.4877262
Ġcontinuing 4.1998725
Ġto 0.03439986
Ġinvest 1.6570661
Ġin 0.18200897
Ġpromising 5.66873
Ġtherapeutic 3.8847857
Ġadvancements 4.7854404
. 0.09789935
ĠAdditionally 3.1624725
, 0.0007294817
Ġcollaborations 10.14991
Ġand 2.8166392
Ġpartnerships 0.9539704
Ġwith 0.74527466
Ġother 2.3704262
Ġindustry 3.2438731
Ġplayers 1.5678805
Ġhave 0.91455734
Ġenabled 2.7641726
Ġthe 0.32875776
Ġsharing 11.556735
Ġof 0.05078977
ĠR 5.0873594
& 0.007408858
D 0.00047678567
Ġcosts 2.51672
Ġand 1.2157162
Ġrisks 7.6870375
, 1.3708612
Ġhelping 3.6978912
Ġto 0.42359924
Ġmitigate 3.2493088
Ġfinancial 5.3159947
Ġpressures 2.5261893
. 0.41505188
Ċ 1.1242684
E 4.3740087
li 0.0125016635
ĠLilly 0.0004887075
Ġ& 0.114134975
ĠCo 0.0042951745
's 1.220016
Ġfuture 5.1868787
Ġperformance 2.8313844
Ġwill 1.2551421
Ġalso 3.4488983
Ġhinge 4.064018
Ġon 0.127325
Ġits 1.1368642
Ġability 0.4529969
Ġto 0.0031148018
Ġmaintain 2.8881352
Ġa 1.6215918
Ġrobust 4.539093
Ġproduct 4.548475
Ġpipeline 0.40424812
. 1.1679317
ĠContinued 5.8116293
Ġsuccess 3.327611
Ġin 0.56550163
Ġnew 6.7733226
Ġdrug 2.4800682
Ġlaunches 1.6529729
Ġwill 1.3995645
Ġbe 1.7343874
Ġvital 3.049134
Ġfor 2.0472968
Ġrevenue 6.576111
Ġgrowth 0.20471008
Ġand 1.3561343
Ġcountering 12.145068
Ġpricing 5.324765
Ġpressures 0.46293992
. 0.40135974
ĠTo 3.5487926
Ġthis 2.4221196
Ġend 0.014540522
, 0.0019439443
Ġthe 0.31282973
Ġcompany 0.02855656
Ġhas 1.158497
Ġactively 5.9285874
Ġpursued 2.6141243
Ġstrategic 3.7266831
Ġacquisitions 2.29184
Ġand 1.9921463
Ġpartnerships 1.3145667
Ġto 1.7688558
Ġexpand 3.003173
Ġits 0.1709224
Ġtherapeutic 4.498425
Ġofferings 1.988341
. 0.5609724
Ċ 1.3866302
Conclusion 5.9755883
: 0.017385866
Ċ 0.031381752
E 1.0891823
li 0.0017213874
ĠLilly 0.00014456424
Ġ& 0.03816714
ĠCo 0.002742673
Ġis 1.8162153
Ġpoised 2.942209
Ġto 0.21424739
Ġreport 2.178379
Ġstrong 1.6053454
Ġthird 2.4380414
- 0.2380209
quarter 0.0060464595
Ġprofits 2.3531356
, 1.3127251
Ġdriven 2.8267028
Ġby 0.0964577
Ġthe 1.7978393
Ġsustained 4.797766
Ġdemand 1.3781403
Ġfor 0.084922686
Ġits 0.13441117
Ġinnovative 1.5817251
Ġdrugs 1.5604506
Ġand 1.470671
Ġsuccessful 4.0525303
Ġproduct 0.61745405
Ġlaunches 0.0341902
. 0.14555441
ĠHowever 2.5060847
, 0.004291105
Ġchallenges 6.444327
Ġsurrounding 5.2243037
Ġprofit 1.8747516
Ġmargins 0.01728513
Ġlo 4.3564963
om 0.002573718
Ġlarge 1.3553984
, 0.85476124
Ġas 2.54892
Ġcompetition 4.334916
Ġand 3.2443678
ĠR 3.2270756
& 0.0005222258
D 0.00037565167
Ġinvestments 3.209147
Ġplace 6.848997
Ġdownward 3.7147677
Ġpressure 0.030626157
Ġon 0.018505484
Ġprofitability 1.8956107
. 0.18260427
ĠAs 2.9361358
Ġthe 1.7502557
Ġcompany 0.3967269
Ġworks 2.5755439
Ġtowards 2.2739713
Ġbalancing 5.8461185
Ġits 1.8400126
Ġfinancial 4.0105896
Ġgoals 2.9571605
Ġwith 0.5060723
Ġits 1.7052175
Ġcommitment 2.9624305
Ġto 0.01158602
Ġadvancing 5.4782705
Ġmedical 4.692945
Ġtreatments 4.439022
, 0.32355753
Ġstakeholders 6.0980997
Ġeagerly 9.192728
Ġawait 0.33884716
Ġits 1.7284582
Ġstrategic 6.639012
Ġplans 2.377598
Ġfor 2.0962079
Ġmanaging 6.8634987
Ġthese 2.3073804
Ġconcerns 4.779946
. 0.1713849
ĠEli 4.6345015
ĠLilly 0.00010772499
Ġ& 0.06290161
ĠCo 0.0038515811
's 1.3407216
Ġability 4.122377
Ġto 0.0047436403
Ġnavigate 2.9595308
Ġthese 0.5067763
Ġchallenges 0.63074493
Ġand 2.5848403
Ġsustain 4.1149106
Ġlong 3.356266
- 0.033077296
term 0.005075897
Ġprofitability 1.3077989
Ġwill 0.8485018
Ġinfluence 7.603655
Ġinvestor 4.847691
Ġsentiment 1.9489006
Ġand 0.9348524
Ġthe 1.6967958
Ġcompany 2.1599114
's 0.011236342
Ġposition 7.1206307
Ġin 0.35858208
Ġthe 0.111440234
Ġpharmaceutical 3.4380808
Ġindustry 0.19341561
. 0.21650757
